Elisenda Anglada Clofent - Institutions of which they are part Predoctoral researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca Neuropsychologist Multiple Sclerosis Centre of Catalonia Email Elisenda Anglada Clofent Email Institutions of which they are part Predoctoral researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca Neuropsychologist Multiple Sclerosis Centre of Catalonia -
Projects SGR-Cat 2021: Neuroimmunologia Clínica IP: SGR-Cat 2021: Neuroimmunologia Clínica Collaborators: Carlos Nos Llopis, SGR-Cat 2021: Neuroimmunologia Clínica, José Ant. Graells Salvador, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Andrea Serrano Mascarós, Margarida Capell Maymo, SGR-Cat 2021: Neuroimmunologia Clínica, Elisenda Anglada Clofent, Montserrat Aroca Alsina, Sergio Cabello, Carmen Tur Gomez, Gabriel Ig Camiña Rodríguez, Herena Eixarch Ahufinger, Carme Santoyo Medina, Oriol Nualart Mundo, SGR-Cat 2021: Neuroimmunologia Clínica, M Jesus Arevalo Navines, SGR-Cat 2021: Neuroimmunologia Clínica, Augusto Cesar Sao Aviles, SGR-Cat 2021: Neuroimmunologia Clínica, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Gaizka Loyola Sanmillan, Mireia Resina Salles, Angela Vidal Jordana, Lucía Gutiérrez Ruiz, Ana Zabalza de Torres, Sergio Vergara Ruiz, Rafael Garcia Merida, Luciana Midaglia Fernandez, Alvaro Cobo Calvo, SGR-Cat 2021: Neuroimmunologia Clínica, Joaquin Castillo Justribo, Milagros Fraga Pereira, Breogan Rodriguez Acevedo, Andres Miguez Gonzalez, Mireia Castillo Juarez, Rucsanda Pinteac, Nicolás Miguel Fissolo Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 40000 Reference: 2021 SGR 00782 Duration: 01/01/2022 - 30/06/2025 Incorporación de la caracterización estructuro-funcional medular por resonancia magnética. Aplicación en la esclerosis múltiple. IP: Deborah Pareto Onghena Collaborators: Jordi Rio Izquierdo, Elisenda Anglada Clofent, Elena Huerga Núñez Funding agency: Instituto de Salud Carlos III Funding: 37510 Reference: PI18/00823 Duration: 01/01/2019 - 30/06/2023
